J Li, P Sun, T Huang, S He, L Li… - Oncology …, 2021 - spandidos-publications.com
Abstract ERCC1, RRM1, TUBB3, TYMS and TOP2A genes have been shown to be associated with drug resistance in various types of tumors; however, their roles in breast …
Y Cao, G Zhang, P Wang, J Zhou, W Gan, Y Song… - BMC …, 2017 - Springer
Background Individualized therapeutic regimen is a recently intensively pursued approach for targeting diseases, in which the search for biomarkers was considered the first and most …
J Lin, G Marquardt, N Mullapudi, T Wang, W Han… - The American journal of …, 2014 - Elsevier
We evaluated the importance of tumor cell selection for generating gene signatures in non– small cell lung cancer. Tumor and nontumor tissue from macroscopically dissected (Macro) …
JA Karlow, EC Pehrsson, X Xing, M Watson… - bioRxiv, 2022 - biorxiv.org
Epigenetic alterations are widespread in cancer and can complement genetic alterations to influence cancer progression and treatment. To better understand the potential contribution …
X Yang, XL Feng, X Wang, Y Fang… - Journal of Biomaterials …, 2016 - ingentaconnect.com
Anthracycline plus paclitaxel is frequently used as the care standard in neoadjuvant chemotherapy for breast cancer patients, however its efficacy varies among individual …
LI Juncheng, P Sun, T Huang, S He, L Li, G Xue - 2019 - researchsquare.com
Objective: ERCC1, RRM1, TUBB3, TYMS and TOP2A gene have been shown to be associated with chemotherapeutic drug resistance. And the aim of the present study was to …
Der Hauptrisikofaktor für die Entstehung von Lungenkarzinomen ist das Tabakrauchen, jedoch erkranken zunehmend auch Nichtraucher an dieser Erkrankung, insbesondere …